|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses | |||||
| General and administrative | |||||
| Selling and marketing | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income/(expense) | |||||
| Other income | |||||
| Total other income/(expense) | |||||
| Loss before provision for income taxes | |||||
| Net loss | |||||
| Preferred stock dividends | |||||
| Net loss attributable to common stockholders | |||||
| Net loss attributable to common stockholders per common share - basic (in Dollars per share) | |||||
| Net loss attributable to common stockholders per common share - diluted (in Dollars per share) | |||||
| Weighted average number of common shares outstanding – basic including prefunded warrants (in Shares) | |||||
| Weighted average number of common shares outstanding – diluted including prefunded warrants (in Shares) | |||||
Loading...